Compounded GLP-1 Marketing Claims: What Patients Should Watch For
Misleading compounded GLP-1 marketing claims to watch for — “generic Ozempic,” “FDA-approved compounded,” guaranteed results — and what the accurate language is.
What compounded GLP-1 marketing claims should patients watch for?
Watch for claims that compounded GLP-1s are “FDA-approved,” “generic Ozempic,” or “generic Zepbound,” and for guaranteed weight-loss promises. None are accurate. Compounded semaglutide and tirzepatide are not FDA-approved finished drug products, there is no generic version of these brand medications, and no provider can guarantee results.
Disclaimer: American Telehealth Review is an editorial resource and does not provide medical advice, diagnosis, or treatment. Compounded medications are not FDA-approved finished drug products and should only be prescribed when clinically appropriate by a licensed healthcare provider. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products.
Claims to distrust
- “FDA-approved compounded semaglutide/tirzepatide”
- “Generic Ozempic” or “generic Zepbound”
- Guaranteed or specific weight-loss amounts
- “No medical review needed”
The accurate framing
Brand medications (Ozempic, Wegovy, Mounjaro, Zepbound) are FDA-approved under their own applications. Brand-name medications such as Ozempic, Wegovy, Mounjaro, and Zepbound are FDA-approved under their own applications. Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. Honest providers use this language plainly.
Frequently asked questions
Is there a generic Ozempic?
No. There is no generic Ozempic, and compounded semaglutide is not a generic or an FDA-approved finished product.
Can a provider guarantee weight loss?
No. Guaranteed-results claims are a marketing red flag.
Sources
- U.S. FDA — Medications containing semaglutide and tirzepatide (fda.gov).
- U.S. FDA — Compounding and the FDA (fda.gov).
- Federation of State Medical Boards — Telemedicine policy resources (fsmb.org).